Aspirin may cut death in women with heart disease

	Tweet

Aspirin may significantly reduce death rates in post-menopausal women with heart disease, according to a long-term observational study reported by researchers on Monday.

“It was shown before and we have shown it again: Aspirin is a life-saving therapy,” said Dr. Jeffery Berger, the study’s lead author.

“Women with cardiovascular disease should be on aspirin” unless there is some medical reason that they cannot tolerate the common, over-the-counter medicine, Berger said.

The study, presented at the American Heart Association scientific sessions, included 8,928 women with heart disease between the ages of 50 and 79, 46 percent of whom were taking either 81 milligrams or 325 mg of aspirin per day.

During six and a half years of follow-up observation, the women taking aspirin had a 17 percent reduction in death from all causes and a 25 percent lower death rate from heart disease, researchers said.

Because it was not a randomized trial, researchers said they could not definitively conclude that aspirin caused the reduction in death rates.

However, Berger said the reduction in death rate was the same in women taking either dose of aspirin. He called for more aspirin dosing studies in women as higher doses are associated with increased risk of side effects, such as gastric bleeding.

“Unfortunately, when you look at the aspirin data, you find that women have been underrepresented in many of the studies,” Berger said.

“There is no conclusive data that provides the optimal dose or effect of aspirin usage in women, but it does appear that 81 mg is as effective as 325 mg,” he said.

He said the findings reported on Monday may not apply to young women with heart disease because only post-menopausal women participated in the study.

RELATED STORIES:
Scientists turn skin cells into beating heart muscle   Too many people get angioplasties, study suggests   New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA   Heart Damage After Chemo Linked to Stress in Cardiac Cells   What’s good or bad for the heart, may be the same for the brain   Warfarin in Heart Failure   Increased Sudden Cardiac Death Rate Among HIV Patients   Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease   Lack of basic evidence hampering prevention of sudden heart attacks in sport   Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study   Heart attack patients taken to PCI hospitals first treated faster   Cameron Health’s under-skin ICD safe, effective

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]